FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Bayer sells subsidiary in €1.2B deal

Bayer has struck a deal to sell its material sciences division, H.C. Starck, to a group of investors for €1.2 billion. Bayer had announced earlier that it was shopping the subsidiary to help cover the cost of acquiring Schering. Germany's H.C. Starck, which makes specialty chemicals and metal and chemical powders, will be positioned for a public offering in three to five years.

- see the press release
- read the Pittsburgh Business Journal report

Related Articles:
Bayer Schering outlines global R&D restructuring. Report
Bayer outbids Merck KGaA for Schering. Report

More stories about restructuring   Mergers and Acqusitions   Merck KgAA   public offering  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 28 + 24?
To combat spam, please solve the math question above.